Bulletin
Investor Alert

New York Markets After Hours

Exact Sciences Corp.

NAS: EXAS

GO
/marketstate/country/us

After Hours

/zigman2/quotes/206653925/composite

$

86.26

Change

0.00 0.00%

Volume

Volume 79,986

Dec 8, 2021, 5:04 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/206653925/composite

Today's close

$ 83.36

$ 86.26

Change

+2.90 +3.48%

Day low

Day high

$80.52

$87.23

Open
Open: 83.66

52 week low

52 week high

$73.41

$159.54

Open

Market cap

$14.36B

Average volume

1.57M

P/E ratio

N/A

Rev. per Employee

$298,278

EPS

-4.98

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/exas

MarketWatch News on EXAS

  1. Exact Sciences downgraded to outperform from strong buy at Raymond James

    8:15 a.m. Nov. 3, 2021

    - Tomi Kilgore

  2. The Man Behind Moderna on What’s Next in Biotech

    10:49 p.m. Oct. 15, 2021

    - Barron's Online

  3. Equipment-Buying Wave Is Coming, and It Should Boost Cisco

    9:15 p.m. Sept. 17, 2021

    - Barron's Online

  4. Will Illumina’s Purchase of Grail Kill Cancer-Test Competition?

    6:49 a.m. Aug. 30, 2021

    - Barron's Online

  5. How Natera Is Defending Its Lead in a $15B Cancer-Testing Market

    9:34 a.m. June 22, 2021

    - Barron's Online

  6. Exact Sciences initiated at strong buy with $160 price target at Raymond James

    6:45 a.m. June 15, 2021

    - Tonya Garcia

  7. Grail Will Begin Selling Its Multi-Cancer Blood Test

    8:10 a.m. June 4, 2021

    - Barron's Online

  8. Exact Sciences stock price target cut to $168 from $226 at Truist

    6:59 a.m. May 12, 2021

    - Tomi Kilgore

  9. ARK Innovation ETF Is Struggling Again—and It May Get Worse

    2:13 p.m. May 6, 2021

    - Barron's Online

  10. How a Simple Blood Test Could Reduce Cancer Deaths

    6:26 a.m. April 12, 2021

    - Barron's Online

  11. The FTC Wants to Block Illumina's Deal for Grail

    7:58 a.m. March 31, 2021

    - Barron's Online

  12. Exact Sciences started at buy with $226 stock price target at Truist

    7:42 a.m. Jan. 28, 2021

    - Tomi Kilgore

  13. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/exas

Other News on EXAS

  1. ARKG: This Strategy Comes With High Risks

    2:30 p.m. Dec. 7, 2021

    - Seeking Alpha

  2. Growth Stock Sell-Off: What Should You Do?

    3:23 p.m. Dec. 1, 2021

    - Zacks.com

  3. Exact Sciences Breaks Up With Pfizer -- Time to Buy?

    5:35 a.m. Dec. 1, 2021

    - Motley Fool

  4. Exact Sciences ends co-promotion deal with Pfizer for Cologuard

    4:59 p.m. Nov. 29, 2021

    - Seeking Alpha

  5. These 2 Cathie Wood Stocks Are Screaming Buys

    6:50 a.m. Nov. 24, 2021

    - Motley Fool

  6. 3 Beaten-Down Genomics Stocks: Can They Recover?

    6:38 a.m. Nov. 16, 2021

    - Motley Fool

  7. Loading more headlines...
/news/pressrelease/company/us/exas

Press Releases on EXAS

  1. Section 32 Raises $740 Million Venture Fund

    7:14 a.m. Nov. 4, 2021

    - PR Newswire - PRF

  2. Exact Sciences announces third quarter 2021 results

    3:05 p.m. Nov. 2, 2021

    - PR Newswire - PRF

  3. Exact Sciences to participate in November investor conferences

    5:00 a.m. Nov. 1, 2021

    - PR Newswire - PRF

  4. MDxHealth Provides Q3-2021 Business Update

    12:00 a.m. Oct. 21, 2021

    - GlobeNewswire

  5. Exact Sciences schedules third quarter 2021 earnings call

    5:00 a.m. Oct. 8, 2021

    - PR Newswire - PRF

  6. Exact Sciences to participate in September investor conferences

    5:00 a.m. Sept. 1, 2021

    - PR Newswire - PRF

  7. Renalytix Appoints Daniel J. Levangie to its Board of Directors

    6:00 a.m. Aug. 30, 2021

    - GlobeNewswire

  8. Molecular Diagnostics Market Size, Share, Trends, Analysis and Forecast 2027

    5:12 a.m. Aug. 25, 2021

    - Market Insight Reports

  9. Loading more headlines...

Rates »

Link to MarketWatch's Slice.